1. 076 Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors. (12th April 2019) Authors: Taylor, Peter C; Fleischmann, Roy; Takeuchi, Tsutomu; Pope, Janet; Genovese, Mark C; Zhu, Baojin; Gaich, Carol; Zhang, Xiang; Dickson, Christina; Quebe, Amanda; Leonardis, Francesco De; Cardoso, Anabela; Kouris, Ilias; Durez, Patrick Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 086 Safety and efficacy of filgotinib in a phase 3 trial of patients with active rheumatoid arthritis and inadequate response or intolerance to biologic disease modifying anti-rheumatic drugs. (12th April 2019) Authors: Walker, David; Genovese, Mark C; Kalunian, Kenneth; Gottenberg, Jacques-Eric; de Vlam, Kurt; Mozaffarian, Neelufar; Bartok, Beatrix; Matzkies, Franziska; Gao, Jie; Guo, Ying; Tasset, Chantal; Sundy, John S; Takeuchi, Tsutomu Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 214 Efficacy and safety of switching from adalimumab to sarilumab in an open-label extensionof a phase III monotherapy trial in patients with active rheumatoid arthritis. (25th April 2018) Authors: Burmester, Gerd R; Fiore, Stefano; Hu, Chih-Chi; Fay, Jon; Lee, Eun Bong; Genovese, Mark C Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 217 Improvementsin remission and low disease activity are achieved with ongoing sarilumabtreatment, in patients with rheumatoid arthritis in two phase III studies. (25th April 2018) Authors: Genovese, Mark C; Mangan, Erin K; Fay, Jon; Kimura, Toshio; van Hoogstraten, Hubert; Fleischmann, Roy Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 233 Durability, maintenance and effects of dose reduction following prolonged treatment with baricitinib. (25th April 2018) Authors: Smolen, Josef S; Dougados, Maxime; Takeuchi, Tsutomu; Genovese, Mark C; Haraoui, Boulos; Klar, Rena; Kavanaugh, Arthur; Alonso, Ricardo B; Dudler, Jean; Taylor, Peter C; Nash, Peter; Zerbini, Cristiano A; Durez, Patrick; Pum, Georg; Arthanari, Subhashini; De Leonardis, Francesco; van Vollenhoven,... Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate. Issue 9 (18th April 2013) Authors: Genovese, Mark C; Lee, Eric; Satterwhite, Julie; Veenhuizen, Melissa; Disch, Damon; Berclaz, Pierre-Yves; Myers, Stephen; Sides, Gregory; Benichou, Olivier Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 9(2013) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis. Issue 2 (23rd June 2016) Authors: Burmester, Gerd R; Landewé, Robert; Genovese, Mark C; Friedman, Alan W; Pfeifer, Nathan D; Varothai, Nupun A; Lacerda, Ana P Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 2(2017) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial. Issue 11 (21st July 2011) Authors: Conaghan, Philip G; Emery, Paul; Østergaard, Mikkel; Keystone, Edward C; Genovese, Mark C; Hsia, Elizabeth C; Xu, Weichun; Rahman, Mahboob U Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 11(2011) Page Start: 1968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis. Issue 1 (23rd November 2022) Authors: Montalban, Xavier; Wallace, Daniel; Genovese, Mark C; Tomic, Davorka; Parsons-Rich, Dana; Le Bolay, Claire; Kao, Amy H; Guehring, Hans Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 94:Issue 1(2023) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate. Issue 6 (3rd May 2010) Authors: Cohen, Stanley B; Keystone, Edward; Genovese, Mark C; Emery, Paul; Peterfy, Charles; Tak, Paul Peter; Cravets, Matt; Shaw, Tim; Hagerty, David Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 6(2010) Page Start: 1158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗